Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Use this GYRE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the GYRE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the GYRE SEC filings page. Lician reads the product cache first so this HTML stays unique to Gyre Therapeutics Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full GYRE income, balance, and cash tables.